The treatment of Allergies & Plantar Psoriasis with vitamins

Allergies and Plantar Psoriasis: Mitamins custom make quality formulas for the treatment of Allergies & Plantar Psoriasis with vitamins. A Allergies & Plantar Psoriasis formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Allergies and Plantar Psoriasis

  • Amount Per Serving
    % DV
    Vitamin A
    5000
    IU
    100%
    Vitamin C
    500
    mg
    833%
    Vitamin D
    200
    IU
    50%
    Folate
    400
    mcg
    100%
    Lactobacillus acidolphilus
    100
    mg
    *
    Omega - 3 Fatty Acids
    1000
    mg
    *
    MSM
    100
    mg
    *
  • Amount Per Serving
    % DV
    Bioflavonoid Concentrate
    100
    mg
    *
    Nettle Extract
    50
    mg
    *
    Quercetin
    100
    mg
    *
    Betaine HCl
    50
    mg
    *
    Thymus
    50
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Allergies and Plantar Psoriasis
Monthly Cost: $25.15
Serving Size:4-5
30 Days Money Back Guarantee
100% Satisfaction Guarantee

Allergies and Plantar Psoriasis Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
Update This Formula
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Joint FDA Advisory Committee Recommends Approval Of TYSABRI® For The Treatment Of Moderate To Severe Crohn's Disease
Elan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDAQ: BIIB) announced today that the Gastrointestinal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee of the U.S. Food and Drug Administration (FDA) voted 12 in favor to 3 opposed, with 2 abstaining, to recommend approval of TYSABRI® (natalizumab) as a treatment for moderate-to-severe Crohn's disease in patients who have failed or cannot tolerate available therapies.
Study Published In Endocrinology Reports Potential Of Modigene Technology To Extend Duration Of Protein Drugs
Modigene Inc. (OTC Bulletin Board: MODG) reported that researchers will publish a study in the October edition of the journal Endocrinology showing that erythropoietin (EPO) linked to Modigene's carboxyl terminal peptide (CTP) technology significantly increased the half-life of standard EPO in animal models.
This information concerning the support of Allergies and Plantar Psoriasis treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Mitamins Logo
Home  Multi-Conditions formulas  Allergies & Hey Fever  Allergies  Allergies and Plantar Psoriasis
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments